WallStreetZenWallStreetZen

NASDAQ: UTMD
Utah Medical Products Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Utah Medical Products earnings were $11.6M for the trailing 12 months ending Sep 30, 2025, with -17.1% growth year over year. The latest UTMD earnings report on Sep 30, 2025 announced Q3 2025 earnings of $2.6M, down 13.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, UTMD reported annual earnings of $13.9M, with -16.6% growth. The next UTMD earnings date is Jan 26, 2026.

UTMD past earnings growth

How has UTMD's earnings growth performed historically?

Company
-17.1%
Industry
10.35%
Market
54.8%
UTMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
UTMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
UTMD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

UTMD earnings history

Current Revenue
$38.6M
Current Earnings
$11.6M
Current Profit Margin
30.1%
UTMD's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

UTMD Return on Equity

Current Company
9.9%
Current Industry
9.6%
Current Market
35.2%
UTMD's Return on Equity (9.9%)... subscribe to Premium to read more.
High Return on Equity Performance

UTMD undefined

Current Company
9.5%
Current Industry
8.3%
UTMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when UTMD announces earnings.

UTMD undefined

Current Company
12.29%
Current Industry
11.1%
UTMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

UTMD vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
UTMD$17.60M$11.62M+2.10%$3.54
INFU$24.16M$5.52M-7.31%$0.26
OSUR-$47.61M-$60.24MN/A-$0.80
NYXH-$81.43M-$97.35MN/A-$2.61
AVR-$82.60M-$84.32MN/A-$2.52
View Top Medical Stocks

UTMD earnings dates

Next earnings date
Jan 26, 2026

Utah Medical Products Earnings Reports & History FAQ

What were Utah Medical Products's earnings last quarter?

On UTMD's earnings call on Invalid Date, Utah Medical Products (NASDAQ: UTMD) reported Q3 2025 earnings per share (EPS) of $0.82, up 19.61% year over year. Total UTMD earnings for the quarter were $2.63 million. In the same quarter last year, Utah Medical Products's earnings per share (EPS) was $1.02.

If you're new to stock investing, here's how to buy Utah Medical Products stock.

When does Utah Medical Products report earnings?

The next UTMD earnings call is Invalid Date. Add UTMD to your watchlist to be reminded of Utah Medical Products's next earnings date.

What was UTMD's earnings growth in the past year?

As of Utah Medical Products's earnings date in Invalid Date, Utah Medical Products's earnings has grown -17.1% year over year. This is 27.45 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 10.35%. UTMD earnings in the past year totalled $11.62 million.

Is Utah Medical Products profitable or losing money?

As of the last Utah Medical Products earnings report, Utah Medical Products is currently profitable. Utah Medical Products's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $11.62 million, a 23.83% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.